# Theriva Biologics, Inc.: Form 8-K, filed May 7, 2025

- Company: [Theriva Biologics, Inc.](/companies/tovx.md) (CIK 894158)
- Form: 8-K
- Filed: 2025-05-07
- Accepted by EDGAR: May 7, 2025, 07:10 ET
- Period: 2025-05-07
- Accession: 0001104659-25-045309
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/894158/000110465925045309/tm2514050d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/894158/000110465925045309/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/894158/000110465925045309/tm2514050d1_8k.htm

Filed May 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-045309. Last ingested by Listed: Nov 2, 2026, 16:32 ET. No prices; not investment advice.